Flagship explainer
How SUPERNUS PHARMACEUTICALS, INC. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $719M | 100% |
| |
| Cost of revenue | $74.6M | 10% |
|
| $644M | 90% |
| |
| −$62.3M | −9% |
| |
| Income before tax | −$49M | −7% |
|
| Income tax | −$10.5M | −1% |
|
| −$38.5M | −5% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001356576-26-000011